Electromed, Inc. (ELMD)

Market Cap	233.94M +14.2%
Revenue (ttm)	73.78M +15.3%
Net Income	11.30M +49.9%
EPS	1.30 +52.9%
Shares Out	8.29M
PE Ratio	21.72
Forward PE	19.40
Dividend	n/a
Ex-Dividend Date	n/a

Volume	145,071
Open	27.76
Previous Close	28.33
Day's Range	27.75 - 28.05
52-Week Range	23.01 - 47.40
Beta	0.46
Analysts	Strong Buy
Price Target	48.50 (+71.8%)
Est. Earnings	Nov 11, 2026

About ELMD

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company provides SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVe...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Aug 13, 2010
• Employees: 197
• Stock Exchange: NYSEAMERICAN
• Ticker Symbol: ELMD
• Website: https://smartvest.com

Financial Performance

In fiscal year 2026, Electromed's revenue was $73.78 million, an increase of 15.27% compared to the previous year's $64.00 million. Earnings were $11.30 million, an increase of 49.94%.

Analyst Summary

According to 2 analysts, the average rating for ELMD stock is "Strong Buy." The 12-month stock price target is $48.5, which is an increase of 71.80% from the latest price.

Price Target

$48.5

(71.80% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Oct 1, 2026

Data Sources Report a data error